CoChat

Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans

Open access
Vollenweider, P, Tappy, L, Randin, D, Schneiter, P, Jéquier, E, Nicod, P, Scherrer, U · 1993 · Journal of Clinical Investigation

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.

Abstract

Euglycemic hyperinsulinemia evokes both sympathetic activation and vasodilation in skeletal muscle, but the mechanism remains unknown. To determine whether insulin per se or insulin-induced stimulation of carbohydrate metabolism is the main excitatory stimulus, we performed, in six healthy lean subjects, simultaneous microneurographic recordings of muscle sympathetic nerve activity, plethysmographic measurements of calf blood flow, and calorimetric determinations of carbohydrate oxidation rate. Measurements were made during 2 h of: (a) insulin/glucose infusion (hyperinsulinemic [6 pmol/kg per min] euglycemic clamp), (b) exogenous glucose infusion at a rate matched to that attained during protocol a, and (c) exogenous fructose infusion at the same rate as for glucose infusion in protocol b. For a comparable rise in carbohydrate oxidation, insulin/glucose infusion that resulted in twofold greater increases in plasma insulin concentrations than did glucose infusion alone, evoked twofold greater increases in both muscle sympathetic nerve activity and calf blood flow. Fructose infusion, which increased carbohydrate oxidation comparably, but had only a minor effect on insulinemia, did not stimulate either muscle sympathetic nerve activity or calf blood flow. These observations suggest that in humans hyperinsulinemia per se, rather than insulin-induced stimulation of carbohydrate metabolism, is the main mechanism that triggers both sympathetic activation and vasodilation in skeletal muscle.

Overview

CoChat Summary

TL;DR

In healthy lean humans, euglycemic hyperinsulinemia increased muscle sympathetic nerve activity (MSNA) and calf blood flow more than glucose infusion alone despite comparable carbohydrate oxidation, while fructose infusion increased carbohydrate oxidation without stimulating MSNA or calf blood flow. The authors conclude that hyperinsulinemia per se, rather than insulin-induced carbohydrate metabolism, is the main trigger for sympathetic activation and skeletal-muscle vasodilation.

Key findings

  • During 2-h insulin/glucose infusion, plasma insulin rose to 376.2±30.0 pmol/liter and increased MSNA burst frequency by 93±18%, calf blood flow by 47±14%, and decreased calf vascular resistance by 19±4%.
  • Glucose infusion alone produced comparable carbohydrate oxidation but a smaller insulin rise (282.6±19.8 pmol/liter) and about half the responses: MSNA burst frequency increased 54±10% and calf blood flow 20±6%.
  • Fructose infusion increased carbohydrate oxidation even more than insulin/glucose or glucose infusion (23±2 vs 21±1 and 20±1 μmol/kg per min at 90–120 min) but caused only a minor insulin rise (37.2±1.9 to 57.0±2.7 pmol/liter) and had no effect on MSNA, calf blood flow, or calf vascular resistance.
  • MSNA and calf blood flow rose significantly at 45 min during insulin/glucose infusion but only at 90 min during glucose infusion; during fructose infusion, glucose oxidation increased by 22±7%.

Methods

  • Six lean, healthy subjects (weight 70.8±4.3 kg, BMI 21.8±0.8 kg/m², age 28±4 yr) underwent 2-h protocols: hyperinsulinemic euglycemic clamp (insulin 6 pmol/kg per min), exogenous glucose infusion matched to the clamp, and fructose infusion matched to glucose; five of six subjects completed fructose infusion.
  • Simultaneous measurements included microneurographic MSNA recordings from the peroneal nerve, venous occlusion plethysmography for calf blood flow, indirect calorimetry for carbohydrate oxidation, and plasma hormone/substrate assays.
  • A fourth protocol in six lean healthy male subjects (age 30±4 yr, BMI 22.9±0.6 kg/m²) used [U-¹³C]glucose infusion and breath ¹³CO₂/plasma [¹³C]glucose enrichment to measure glucose oxidation during fructose infusion.
  • Statistical analysis used repeated-measures ANOVA, paired t tests with Bonferroni adjustment, and least-squares correlations; P<0.05 was significant.

Limitations

  • The paper states that indirect calorimetry cannot differentiate glucose from fructose oxidation, that nonoxidative glucose disposal calculations were not performed during fructose infusion because endogenous glucose production was not measured and is not suppressed, and that total carbohydrate uptake may have been slightly higher during fructose infusion.
  • The paper states that the experiments do not elucidate the underlying mechanisms of insulin-induced sympathetic activation and vasodilation, and that MSNA recordings were targeted specifically at skeletal muscle, so fructose-induced sympathetic outflow to other tissues such as liver cannot be excluded.
  • Evident from the text: the main protocols included only six lean healthy subjects (five for fructose), limiting generalizability; the fourth protocol included only male subjects, and the study did not measure interstitial insulin directly.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci116542

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

11 Valid · 0 Not valid · 16 Not checked · 51 Own results and interpretations

47 more claims

Create a free account to see all 78 claims and to verify the 5 references still open.

See all claims — free account
  • Probably not a substantial claim. 14
  • It may state two separate claims as one. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 55 references

Cited by

See all 323

Metadata

Authors
Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U.
Affiliations
Centre Hospitalier Universitaire Vaudois (CH)
Venue
Journal of Clinical Investigation
Published
1993-07-01
Volume
92
Issue
1
Pages
147-154
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2126021651
Cited by
321
References
55
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 11 · 2016: 12 · 2015: 7 · 2014: 9 · 2013: 12 · 2012: 15
FWCI
47.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (28668)
  • Nestec
Topics
  • Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
hyperinsulinemia, euglycemic clamp, muscle sympathetic nerve activity, skeletal muscle blood flow, carbohydrate metabolism, fructose infusion, glucose infusion, insulin, vasodilation, carbohydrate oxidation, energy expenditure
MeSH terms
Adult, Blood Glucose, Calorimetry, Catecholamines, Energy Metabolism, Fructose, Humans, Insulin, Muscles, Potassium, Regional Blood Flow, Sympathetic Nervous System, Vascular Resistance, Carbohydrate Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. https://app.cochat.ai/papers/10.1172/jci116542
The paper
Vollenweider, P., Tappy, L., Randin, D., Schneiter, P., Jéquier, E., Nicod, P., & Scherrer, U. (1993). Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. Journal of Clinical Investigation. https://doi.org/10.1172/jci116542

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.